Prescription drug benefit in the Medicare program: hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, second session, March 22 and 29, 2000, Volume 49
U.S. G.P.O., 2001 - Medical - 222 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Levin Alan B chairman president and chief executive officer Happy Har
WEDNESDAY MARCH 29 2000
7 other sections not shown
200 percent actuarial Administration adverse selection affordable annual approach believe Breaux-Frist Chairman committee competitive Congress copayment cover deductible drug expenditures drug spending drug utilization review DTC advertising eligible employees enrollees enrollment erage expensive Federal FEHBP formulary going HCFA health insurance health plans HMOs Holmer Hustead income increase issue low-income manufacturers Medi Medicaid Medicare beneficiaries Medicare drug benefit Medicare prescription drug Medicare program Medicare reform Medicare+Choice plans medicines Medigap Medigap policies million O'Sullivan offer options out-of-pocket costs outpatient patients payments PBMs percent of poverty pharmaceutical pharmacists pharmacy benefit managers physician premiums prescription drug benefit prescription drug costs prescription drug coverage prescription drug plan price controls private insurance private sector proposal provide prescription drug purchase question rebates retiree risk Scanlon Senator Breaux Senator Jeffords Senator Moynihan senior citizens SenioRx Gold stop-loss subsidy Thank tion drug U.S. SENATOR utilization